PLSH OTC
Panacea Life Sciences Holdings, Inc.
1W: +6.2%
1M: -15.0%
3M: +6.2%
YTD: +70.0%
1Y: +14.9%
3Y: -75.7%
$0.09
+0.03 (+41.67%)
Weekly Expected Move ±29.6%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Income Trends
Revenue
$911K
-77.8% ▼
5Y CAGR: -36.8%
Gross Profit
-$1M
-142.8% ▼
Operating Income
-$2M
+31.9% ▲
Net Income
-$417K
+28.6% ▲
EPS (Diluted)
$-0.01
+77.8% ▲
EBITDA
$18K
-99.2% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $4M | $911K |
| YoY Growth | -77.2% | -21.0% | +46.6% | +72.2% | -77.8% |
| Cost of Revenue | $2M | $1M | $6M | $1M | $2M |
| Gross Profit | $541K | $396K | -$4M | $3M | -$1M |
| Gross Margin | 26.2% | 24.4% | -171.5% | 69.4% | -133.9% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2M | $1M | $1M | $5M | $534K |
| Operating Expenses | $6M | $6M | $2M | $5M | $534K |
| Operating Income | -$6M | -$5M | -$6M | -$3M | -$2M |
| Operating Margin | -269.0% | -331.8% | -232.5% | -62.7% | -192.6% |
| Interest Expense | $1M | $2M | $2M | $2M | $966K |
| Income Before Tax | -$5M | -$9M | -$8M | -$583K | -$417K |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$6M | -$11M | -$8M | -$583K | -$417K |
| Net Margin | -297.3% | -682.1% | -336.1% | -14.2% | -45.8% |
| EPS (Diluted) | $-0.34 | $-0.75 | $-0.48 | $-0.03 | $-0.01 |
| EBITDA | -$2M | -$5M | -$5M | $2M | $18K |
| Shares Outstanding | 18M | 15M | 17M | 18M | 59M |